Immune system study for dengue, flu, and sepsis patients
Part of Infections, Lungs & breathing clinical trials.
This study looks at how the immune system responds to dengue, flu, and sepsis. It may help doctors understand these illnesses better and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have dengue-like symptoms (fever over 100.4°F plus at least two other symptoms like headache, muscle pain, or rash) that started within the last 3 days.
- You have the flu (fever and cough that started within the last 4 days, and a positive flu test).
- You have sepsis (admitted to the hospital less than 48 hours ago, with blood cultures ordered and antibiotics started).
- You are a healthy person with no chronic illness, no regular medications, and no fever in the last 28 days.
- You are at least 2 years old, not pregnant, not breastfeeding, and have not been pregnant in the last 90 days.
- You do not have serious health conditions like autoimmune disease, cancer, diabetes, or HIV, and you have not taken long-term immune-suppressing drugs or NSAIDs (like ibuprofen) recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This study collects blood samples from people with suspected or confirmed dengue to help improve testing. Participation may help researchers understand the disease better and could lead to better diagnostics.
This study looks at how your immune system fights off flu or COVID-19. If you have a current or recent infection, or if you've been vaccinated in the past year, you may be able to join.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This study follows patients hospitalised with dengue to better understand the disease and improve future research. If you are in the hospital with confirmed dengue, you may be eligible to join.
Hear when a new Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.